These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 33250514)

  • 1. Tumor-suppressive microRNA-551b-3p targets H6PD to inhibit gallbladder cancer progression.
    Ji T; Gao L; Yu Z
    Cancer Gene Ther; 2021 Jun; 28(6):693-705. PubMed ID: 33250514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-551b regulates epithelial-mesenchymal transition and metastasis of gastric cancer by inhibiting ERBB4 expression.
    Song G; Zhang H; Chen C; Gong L; Chen B; Zhao S; Shi J; Xu J; Ye Z
    Oncotarget; 2017 Jul; 8(28):45725-45735. PubMed ID: 28501849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Up-regulated microRNA-33b inhibits epithelial-mesenchymal transition in gallbladder cancer through down-regulating CROCC.
    Xu G; Wei X; Tu Q; Zhou C
    Biosci Rep; 2020 Jan; 40(1):. PubMed ID: 31799620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. miR-101 targeting ZFX suppresses tumor proliferation and metastasis by regulating the MAPK/Erk and Smad pathways in gallbladder carcinoma.
    Bao RF; Shu YJ; Hu YP; Wang XA; Zhang F; Liang HB; Ye YY; Li HF; Xiang SS; Weng H; Cao Y; Wu XS; Li ML; Wu WG; Zhang YJ; Jiang L; Dong Q; Liu YB
    Oncotarget; 2016 Apr; 7(16):22339-54. PubMed ID: 26968949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MiR-20a triggers metastasis of gallbladder carcinoma.
    Chang Y; Liu C; Yang J; Liu G; Feng F; Tang J; Hu L; Li L; Jiang F; Chen C; Wang R; Yang Y; Jiang X; Wu M; Chen L; Wang H
    J Hepatol; 2013 Sep; 59(3):518-27. PubMed ID: 23665284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-551b-3p inhibits tumour growth of human cholangiocarcinoma by targeting Cyclin D1.
    Chang W; Wang Y; Li W; Shi L; Geng Z
    J Cell Mol Med; 2019 Aug; 23(8):4945-4954. PubMed ID: 31199052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-throughput screening identified miR-7-2-3p and miR-29c-3p as metastasis suppressors in gallbladder carcinoma.
    Lu K; Feng F; Yang Y; Liu K; Duan J; Liu H; Yang J; Wu M; Liu C; Chang Y
    J Gastroenterol; 2020 Jan; 55(1):51-66. PubMed ID: 31562534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting of NT5E by miR-30b and miR-340 attenuates proliferation, invasion and migration of gallbladder carcinoma.
    Wang N; Xiang X; Chen K; Liu P; Zhu A
    Biochimie; 2018 Mar; 146():56-67. PubMed ID: 29155108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The microRNA cluster miR-214/miR-3120 prevents tumor cell switching from an epithelial to a mesenchymal-like phenotype and inhibits autophagy in gallbladder cancer.
    Li W; Yan P; Meng X; Zhang J; Yang Y
    Cell Signal; 2021 Apr; 80():109887. PubMed ID: 33340658
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulation of microRNA-140-3p inhibits epithelial-mesenchymal transition, invasion, and metastasis of hepatocellular carcinoma through inactivation of the MAPK signaling pathway by targeting GRN.
    Zhang QY; Men CJ; Ding XW
    J Cell Biochem; 2019 Sep; 120(9):14885-14898. PubMed ID: 31044454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The microRNA miR-33a suppresses IL-6-induced tumor progression by binding Twist in gallbladder cancer.
    Zhang M; Gong W; Zuo B; Chu B; Tang Z; Zhang Y; Yang Y; Zhou D; Weng M; Qin Y; Ma M; Jiang A; Ma F; Quan Z
    Oncotarget; 2016 Nov; 7(48):78640-78652. PubMed ID: 27769047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-506 inhibits tumor growth and metastasis in nasopharyngeal carcinoma through the inactivation of the Wnt/β-catenin signaling pathway by down-regulating LHX2.
    Liang TS; Zheng YJ; Wang J; Zhao JY; Yang DK; Liu ZS
    J Exp Clin Cancer Res; 2019 Feb; 38(1):97. PubMed ID: 30791932
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of microRNA-141-3p in the progression and metastasis of hepatocellular carcinoma cell.
    Hou X; Yang L; Jiang X; Liu Z; Li X; Xie S; Li G; Liu J
    Int J Biol Macromol; 2019 May; 128():331-339. PubMed ID: 30695725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non-coding RNA H19 regulates FOXM1 expression by competitively binding endogenous miR-342-3p in gallbladder cancer.
    Wang SH; Ma F; Tang ZH; Wu XC; Cai Q; Zhang MD; Weng MZ; Zhou D; Wang JD; Quan ZW
    J Exp Clin Cancer Res; 2016 Oct; 35(1):160. PubMed ID: 27716361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-520c-3p negatively regulates EMT by targeting IL-8 to suppress the invasion and migration of breast cancer.
    Tang CP; Zhou HJ; Qin J; Luo Y; Zhang T
    Oncol Rep; 2017 Nov; 38(5):3144-3152. PubMed ID: 29048659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-128-3p Enhances the Chemosensitivity of Temozolomide in Glioblastoma by Targeting c-Met and EMT.
    Zhao C; Guo R; Guan F; Ma S; Li M; Wu J; Liu X; Li H; Yang B
    Sci Rep; 2020 Jun; 10(1):9471. PubMed ID: 32528036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-144-3p Represses the Growth and EMT of Thyroid Cancer via the E2F2/TNIK Axis in Cells and Male BALB/c Nude Mice.
    Yi D; Zhang D; Zeng Z; Zhang S; Li M; Zhang Y
    Endocrinology; 2022 Jul; 163(7):. PubMed ID: 35579981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of SNORA21 suppresses tumorgenesis of gallbladder cancer in vitro and in vivo.
    Qin Y; Zhou Y; Ge A; Chang L; Shi H; Fu Y; Luo Q
    Biomed Pharmacother; 2019 Oct; 118():109266. PubMed ID: 31401397
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exosomal microRNA-551b-3p from bone marrow-derived mesenchymal stromal cells inhibits breast cancer progression via regulating TRIM31/Akt signaling.
    Yang Z; Xu B; Wu S; Yang W; Luo R; Geng S; Xin Z; Jin W; Shen X; Gu X; Zhang H; Wang H
    Hum Cell; 2022 Nov; 35(6):1797-1812. PubMed ID: 35941326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miR-22 and miR-214 targeting BCL9L inhibit proliferation, metastasis, and epithelial-mesenchymal transition by down-regulating Wnt signaling in colon cancer.
    Sun R; Liu Z; Han L; Yang Y; Wu F; Jiang Q; Zhang H; Ma R; Miao J; He K; Wang X; Zhou D; Huang C
    FASEB J; 2019 Apr; 33(4):5411-5424. PubMed ID: 30698996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.